论文信息 - Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors. - 字舞流文

Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors.

F. Perrone | M. Milione | G. Lo Russo | F. de Braud | E. Tamborini | F. Corti | S. Pusceddu | R. Buzzoni | N. Prinzi | C. Vernieri | I. Pulice | Daniela Femia | L. Concas